DotLab
Bringing you DotEndo for Endometriosis
San Francisco, United States · Founded 2016 · $10.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- dotlab.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series AMay 2019
- Rounds
- 1
About
Women's health diagnostics company offering DotEndo, the first non-invasive blood test for endometriosis using microRNA biomarkers.
Summary
DotLab is a Healthcare company based in San Francisco, United States, founded in 2016. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in May 2019. Investors include CooperSurgical, Tiger Global and Luxor Capital Group.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2019
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dotlab"><img src="https://indexed.vc/api/badge/company/dotlab" alt="DotLab on Indexed.vc" width="260" height="76" /></a>